New anklets help people with diabetes relieve pain

Wearable medical devices are about to become popular today, but most devices are mainly for the monitoring of vital signs and nothing more. However, NeuroMetrix, a company founded by Harvard's Department of Health Sciences and Technology, has officially launched an unusual new device that is aimed primarily at people with diabetes and chronic pain. It aims to provide non-drug relieving pain to the wearer.

NeuroMetrix Sensus

The original design concept of NeuroMetrix Sensus was to use no drugs to relieve pain for diabetic patients, which may become the most promising medical device in the next few years. Although this device can only alleviate the pain in the foot and calf, it is very important that it is non-addictive, does not use any drugs, does not have side effects, just start the switch, the use process is very simple and effective. The appearance of NeuroMetrix Sensus is the same as that of an ordinary anklet. Wearing it on either or both calfs will make it obvious if you wear tight jeans, but if you wear boots or regular trousers, there is no problem. Such patients in need can fully wear NeuroMetrix Sensus to work without any interference. In addition, Sensus is programmable to help patients relieve pain for a predetermined period of time.

NeuroMetrix Sensus Working Principle NeuroMetrix SENSUS is used to relieve pain through the use of transcutaneous nerve stimulation (TENS) technology to stimulate muscles. Percutaneous nerve stimulation technology has been widely used to treat chronic diseases including diabetic neuropathy. After the device is turned on, it can provide temporary or long-lasting treatment according to the patient's settings. Sensus provides personalized settings when the patient is first used to ensure that the appropriate electrical stimulation intensity is provided. Currently Sensus is the only prescription device that doctors can order and send to the patient's home. Sensus also has a dormancy function, which the user can set to ease the pain during sleep. This is the first device that can be worn at night. The recommended dose is one hour per day, the battery lasts up to two weeks and can be recharged. .

Problems In the vast majority of cases, Sensus has a significant effect in alleviating pain in the feet and calves. However, neuroradiotherapy is not suitable for patients with epilepsy and pregnant women. In addition, there is not much research to prove that TENS can significantly reduce pain, but there is considerable Some studies have shown that it is effective; it may be more effective in patients with diabetic neuropathy.

In spite of this, Sensus has been approved by the U.S. FDA, which is definitely a product worth looking forward to. Diabetic neuropathy is a $1.4 billion industry. If you can use no-drug therapies at home to relieve pain, this is a step in the right direction from any angle. In fact, some insurance agencies may bear the cost of treating patients with diabetes.

Since Sensus costs from $400 to $1,200, depending on the retailer, this is actually much more efficient than paying more for medication.